| Financial Year |
March 31 2023 |
| Monetary Funds |
42,933,481.60 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
68,014,161.28 |
| Advances to Suppliers |
11,134,941.78 |
| Other Receivables |
1,828,928.06 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
164,340,165.06 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
5,967,846.67 |
| Total Current Assets |
297,969,316.53 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
23,741,938.63 |
| Investment Properties |
-- |
| Fixed Assetes |
670,733,334.61 |
| Under-construction Projects |
8,244,653.76 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
55,948,354.49 |
| R&D expenses |
-- |
| Goodwill |
65,966,311.97 |
| Long-Term Deferred and Prepaid Expenses |
174,528.31 |
| Deferred Income Tax Assets |
7,307,343.88 |
| Other Non-Current Assets |
21,997,899.74 |
| Sub-Total of Non-Current Assets |
878,594,885.37 |
| Total Assets |
1,176,564,201.90 |
| Short-Term Loans |
230,241,296.42 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
111,037,485.98 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
6,138,399.88 |
| Taxes Payable |
1,122,714.10 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
12,513,469.64 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
81,147,974.05 |
| Other Current Liabilities |
294,498.21 |
| Sub-Total of Current Liabilities |
450,418,896.38 |
| Long-term Loans |
91,610,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
36,414,679.15 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
5,126,237.75 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
137,261,512.38 |
| Total Liabilities |
587,680,408.76 |
| Paid-In Capital(Or Share Stock) |
155,415,837.00 |
| Capital Surplus |
340,471,788.21 |
| Surplus Reserve |
53,384,343.36 |
| LESS:Treasury Stock |
32,426,048.56 |
| Undistributed Profits |
64,790,437.89 |
| Minority Stockholder's Interest |
3,340,279.68 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
585,543,513.46 |
| Owner's Equity（Stockholder's Equity） |
588,883,793.14 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,176,564,201.90 |
